267) Cancer survivors also have more problems i |
268) Cancer survivors have the lowest HRQoL sca |
269) health-related quality of life (HRQoL) of cancer survivors against that of cardiovas |
270) Breast cancer survivors are more likely to seek c |
271) The study suggests that cancer survivors should receive more inten |
272) The HRQoL of young cancer survivors was as impaired as that o |
273) experience in taking care of Thai breast cancer survivors who used CAM from a terti |
274) be concerned about CAM use in Thai breast cancer survivors. |
275) es perceive the use of CAM in Thai breast cancer survivors. |
276) ypofractionated radiotherapy for prostate cancer with a rectal balloon, total delive |
277) an extremely rare case of familial breast cancer with deleterious germline mutations |
278) 90 Caucasian unrelated women with breast cancer with familial criteria and 96 contr |
279) oint effects of increased risk of bladder cancer with increasing number of unfavorab |
280) e report a patient with end-stage ovarian cancer with peritoneal carcinomatosis and |
281) ios and 95% confidence intervals for oral cancer with respect to betel quid were inc |
282) Colorectal cancer with the presence of an abdominal a |
283) predicting bone structural remodelling in cancer are also briefly discussed. |
284) The hallmarks of cancer are described as the distinctive an |
285) n tumorigenesis and genetic complexity in cancer are discussed. |
286) s screening and early detection of breast cancer are important in reducing cancer mo |
287) long-regarded risk factors for esophageal cancer are tobacco, alcohol, and reflux es |
288) epidemiologic complexities of esophageal cancer are vast, rendering screening and p |
289) source of agents for NFκB inhibition in cancer therapy. |
290) echanisms that favor their application in cancer therapy. |
291) c miRNAs as potential tools or targets in cancer therapy. |
292) y of life as a consequence of the primary cancer therapy. |
293) expectations for possible applications in cancer therapy. |
294) possible mechanisms for its role in liver cancer therapy. |
295) gnificantly decreased or silenced in lung cancer tissues and cell lines associated w |
296) in TAMs was analyzed in human pancreatic cancer tissues and in a genetic mouse mode |
297) hylation in 52 of 98 (53.1%) primary lung cancer tissues and in nine of 10 (90%) cel |
298) ein expression was performed using breast cancer tissues from the proband with doubl |
299) Therefore, we analyzed mouse skin cancer tissues induced by the 2-stage carc |
|